Immuneering Corporation (IMRX) Tops Q2 EPS by 2c

Immuneering Corporation (NASDAQ: IMRX) reported Q2 EPS of ($0.40), $0.02 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• loanDepot receives NYSE non-compliance notice over stock price
• Oruka Therapeutics (ORKA) files $1B mixed shelf
• Solowin Holdings marks 10 years, expands into stablecoins and AI